Colossal

Operator of a bioscience and genetic engineering company committed to building radical new technologies to advance the field of genomics.

LBX PPS

1Y return

$11.10

Implied Valuation

$4.5B

-55.4% premium

Last Round

$24.89

Series C · $10.2B

Activity

2.8

#70 most active

Price per share

12M · USD

Loading chart...

Funding history

$M raised · $B post-money

Loading chart...

Signals

1 latest

May 20

Colossal CEO Says Artificial Womb for Mammals Is Near Completion

Colossal's CEO stated that the company's artificial womb technology for growing mammals is at the 'one-yard line,' signaling a major near-term milestone in its de-extinction and reproductive technology efforts.

Source: Decrypt